Testosterone Level Decline, often termed andropause or late-onset hypogonadism in clinical settings, signifies a significant, sustained reduction in circulating free and total testosterone concentrations below established healthy reference intervals for a given age cohort. This reduction impacts numerous physiological domains, including muscle maintenance, libido, and cognitive function. Monitoring this trend is a key component of male hormonal health assessment. The decline represents a quantifiable endocrine shift.
Origin
This phrase is derived from the specific androgen, testosterone, and the observation of its gradual reduction over the lifespan, a process common in aging physiology. Its study originates in endocrinology, particularly concerning the aging male and the impact of chronic disease on gonadal function. The decline is often relative to the individual’s prior physiological peak.
Mechanism
The decline mechanism can be primary, originating from testicular dysfunction, or secondary, stemming from hypothalamic-pituitary axis impairment, such as chronic stress affecting GnRH pulsatility. Decreased sensitivity of Leydig cells to LH stimulation is a frequent contributing factor in age-related decline. Furthermore, increases in Sex Hormone-Binding Globulin (SHBG) can lower the biologically active free fraction, even if total levels are only marginally affected.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.